根据最近的ESGO/ESTRO/ESP指南,根据预后风险组,根据早期子宫内膜癌的辅助治疗算法
Jean-Francois Baurain1, Carine Kirkove2, Aline Francois3
1Department of Medical Oncology, UNGO, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. jf.baurain@uclouvain.be.
Journal of gynecologic oncology
|November 14, 2025
概括
本指南通过整合分子分析和更新的风险类别,简化了早期子宫内膜癌 (EC) 的辅助治疗. 它帮助临床医生为EC患者做出复杂的治疗决策.
科学领域:
- 妇科瘤学 妇科瘤学
- 分子病理学分子病理学
- 临床指南 临床指南
背景情况:
- 子宫内膜癌 (EC) 的发病率正在上升,早期诊断和手术是主要的治疗方法.
- 对于EC的辅助疗法选择传统上依赖于组织学因素,但分子分类提供了优越的预后价值.
- 2023年国际妇科和产科联合会的分期系统现在将分子生物标志物与组织学一起纳入.
研究的目的:
- 为早期子宫内膜癌 (EC) 的辅助治疗制定一个实用的口袋指南.
- 综合当前的临床试验数据和现有的辅助EC治疗指南.
- 为 RAINBO 研究计划中的未来临床试验整合提供一个框架.
主要方法:
- 临床试验的审查在辅助剂设置的早期阶段EC.
- 分析欧盟管理现有的欧洲和国际指导方针.
- 将分子分析和更新的分期系统整合到治疗建议中.
主要成果:
- 癌症基因组图谱 (TCGA) 项目强调了分子分类在EC预后方面的优越性.
- 2023年FIGO分期系统是第一个将分子和形态组织学数据结合起来.
- 更新的2025年欧洲指南将EC分为4个风险组,具有不同的辅助治疗.
结论:
- 提出了一项实际指南,以简化早期EC的辅助治疗决策.
- 分子分析和淋巴结评估对所有EC患者至关重要.
- 该指南旨在帮助临床医生管理复杂的EC辅助疗法环境.
相关概念视频
Cancer Survival Analysis
634
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
634
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Esophageal Varices-II: Clinical Features and Management
355
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
355


